Geoffroy Liégeon

1.6k total citations
25 papers, 166 citations indexed

About

Geoffroy Liégeon is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Geoffroy Liégeon has authored 25 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Geoffroy Liégeon's work include HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (9 papers) and HIV/AIDS drug development and treatment (9 papers). Geoffroy Liégeon is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (9 papers) and HIV/AIDS drug development and treatment (9 papers). Geoffroy Liégeon collaborates with scholars based in France, United States and United Kingdom. Geoffroy Liégeon's co-authors include Jade Ghosn, Mathieu Picardeau, Tristan Delory, José M. Miró, Montserrat Laguno, Juan Ambrosioni, Jean‐Michel Molina, Constance Delaugerre, Amy K. Johnson and Samantha A. Devlin and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Geoffroy Liégeon

18 papers receiving 162 citations

Peers

Geoffroy Liégeon
Rémy Demeester Belgium
Anne-Sophie Sauvage Belgium
Mariano Matarranz Spain
Hermione Lyall United Kingdom
Anne Brink Philippines
Mariana Ceriotto Argentina
Anemaw Asrat Ethiopia
Evelyn Ngige Nigeria
Catherine Glover Australia
Chase A. Cannon United States
Rémy Demeester Belgium
Geoffroy Liégeon
Citations per year, relative to Geoffroy Liégeon Geoffroy Liégeon (= 1×) peers Rémy Demeester

Countries citing papers authored by Geoffroy Liégeon

Since Specialization
Citations

This map shows the geographic impact of Geoffroy Liégeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffroy Liégeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffroy Liégeon more than expected).

Fields of papers citing papers by Geoffroy Liégeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffroy Liégeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffroy Liégeon. The network helps show where Geoffroy Liégeon may publish in the future.

Co-authorship network of co-authors of Geoffroy Liégeon

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffroy Liégeon. A scholar is included among the top collaborators of Geoffroy Liégeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffroy Liégeon. Geoffroy Liégeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liégeon, Geoffroy, Eleanor E. Friedman, Kristen A. Stafford, et al.. (2025). Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic. Open Forum Infectious Diseases. 12(3). ofaf094–ofaf094.
2.
Berçot, Béatrice, Lambert Assoumou, François Caméléna, et al.. (2025). Antimicrobial-Resistant Neisseria gonorrhoeae Infections in Men Using Doxycycline Postexposure Prophylaxis: A Substudy of the ANRS 174 DOXYVAC Trial. Clinical Infectious Diseases.
3.
Friedman, Eleanor E., Samantha A. Devlin, Geoffroy Liégeon, et al.. (2025). PrEP Prescriptions at 2 Federally Qualified Health Centers. Sexually Transmitted Diseases. 53(3). e26–e28.
4.
5.
Chaix, Marie‐Laure, Karl Stéfic, Caroline Lascoux‐Combe, et al.. (2024). Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023. Journal of Medical Virology. 96(10). e29948–e29948. 3 indexed citations
6.
Liégeon, Geoffroy, Samantha A. Devlin, Victoria Manda, et al.. (2024). Knowledge, Attitudes, and Perspectives of Women Who Have Migrated from Sub-Saharan Africa to France Toward HIV Pre-Exposure Prophylaxis in a Family Planning Center. AIDS Patient Care and STDs. 38(11). 507–516. 3 indexed citations
7.
Liégeon, Geoffroy, Constance Delaugerre, & Jean‐Michel Molina. (2024). HIV Pre-Exposure Prophylaxis. Infectious Disease Clinics of North America. 38(3). 453–474. 3 indexed citations
8.
Devlin, Samantha A., Amy K. Johnson, Geoffroy Liégeon, et al.. (2024). Increasing providers’ PrEP prescription for Black cisgender women: A qualitative study to improve provider knowledge and competency via PrEP training. Women s Health. 20. 912688662–912688662.
9.
Rubenstein, Emma, Myriam Diemer, Caroline Lascoux‐Combe, et al.. (2024). Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine. AIDS. 38(8). 1267–1269. 10 indexed citations
10.
Devlin, Samantha A., Jessica P. Ridgway, Geoffroy Liégeon, et al.. (2023). Adapting Provider Training and Pre-Exposure Prophylaxis Advertising to Increase Pre-Exposure Prophylaxis Awareness and Uptake Among Black Cisgender Women. AIDS Patient Care and STDs. 37(12). 574–582. 13 indexed citations
11.
12.
Liégeon, Geoffroy & Jade Ghosn. (2022). Long‐acting injectable cabotegravir forPrEP: A game‐changer inHIVprevention?. HIV Medicine. 24(6). 653–663. 29 indexed citations
13.
Liégeon, Geoffroy. (2022). Safety of oral tenofovir disoproxil - emtricitabine for HIV preexposure prophylaxis in adults. Current Opinion in HIV and AIDS. 17(4). 199–204. 5 indexed citations
14.
Liégeon, Geoffroy, Nicole Ngo‐Giang‐Huong, Nicolas Salvadori, et al.. (2021). Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus. Journal of Antimicrobial Chemotherapy. 77(4). 1111–1118. 1 indexed citations
15.
Crichi, Benjamin, Corinne Frère, Philippe Bonnin, et al.. (2020). How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. JMV-Journal de Médecine Vasculaire. 45(6). 334–343. 13 indexed citations
16.
Ambrosioni, Juan, et al.. (2020). Primary HIV-1 infection in users of pre-exposure prophylaxis. The Lancet HIV. 8(3). e166–e174. 34 indexed citations
17.
Liégeon, Geoffroy, Guillemette Antoni, Gilles Pialoux, et al.. (2020). Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis. Journal of the International AIDS Society. 23(2). e25420–e25420. 11 indexed citations
18.
Liégeon, Geoffroy, Linda Harrison, Panita Pathipvanich, et al.. (2019). Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors. Journal of Infection. 79(5). 454–461. 1 indexed citations
19.
Liégeon, Geoffroy, Tristan Delory, & Mathieu Picardeau. (2018). Antibiotic susceptibilities of livestock isolates of leptospira. International Journal of Antimicrobial Agents. 51(5). 693–699. 25 indexed citations
20.
Roux, Alexandre, Alice Sanna, Geoffroy Liégeon, et al.. (2018). Clinical Features, Diagnosis, and Outcome of Encephalitis in French Guiana. American Journal of Tropical Medicine and Hygiene. 100(2). 452–459. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rémy Demeester Breakdown of academic impact, for papers by Anne-Sophie Sauvage Breakdown of academic impact, for papers by Mariano Matarranz Breakdown of academic impact, for papers by Hermione Lyall Breakdown of academic impact, for papers by Anne Brink Breakdown of academic impact, for papers by Mariana Ceriotto Breakdown of academic impact, for papers by Anemaw Asrat Breakdown of academic impact, for papers by Evelyn Ngige Breakdown of academic impact, for papers by Catherine Glover Breakdown of academic impact, for papers by Chase A. Cannon
Rankless by CCL
2026